Comparative Antiresorptive Efficacy Discontinuation of Denosumab
Comparative Antiresorptive Efficacy Discontinuation of Denosumab
Active, not recruiting · NCT03623633 · Registry updated 2023-06-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparative Antiresorptive Efficacy Discontinuation of Denosumab | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis | Active, not recruiting | Phase 4 | 2023-06-07 | NCT03623633 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Massachusetts General Hospital | 758 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |